Clinical Trial Update: Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) [Phase 2]

View source ↗

Summary

Phase 2 trial update for momelotinib in transfusion-dependent adults with primary myelofibrosis and related post-PV/ET myelofibrosis; trial completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• Momelotinib (momelotinib)

Snippet

Sponsor: Sierra Oncology LLC - a GSK company | Conditions: Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-01-20